The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2014

Filed:

May. 29, 2012
Applicants:

Peter Geigle, Alzenau, DE;

Christine Wallrapp, Grossostheim, DE;

Eric Thoenes, Budingen, DE;

Inventors:

Peter Geigle, Alzenau, DE;

Christine Wallrapp, Grossostheim, DE;

Eric Thoenes, Budingen, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); C07K 14/605 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01);
Abstract

The present invention provides fusion peptides having GLP-1 activity and enhanced stability in vivo, in particular resistancy to dipeptidyl peptidase IV. The fusion peptide comprises as component (I) N-terminally a GLP-1(7-35, 7-36 or 7-37) sequence and as component (II) C-terminally a peptide sequence of at least 9 amino acids or a functional fragment, variant or derivative thereof. Component (II) is preferably a full or partial version of IP2 (intervening peptide 2). A preferred embodiment comprises the sequence GLP-1(7-35, 36 or 37)/IP2/GLP-1(7-35, 36 or 37) or GLP-2. The fusion peptide may be produced in engineered cells or synthetically and may be used for preparing a medicament for treating various diseases or disorders, e.g. diabetes type 1 or 2, apoptosis related diseases or neurodegenerative disorders.


Find Patent Forward Citations

Loading…